STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – KTRA, CHX, NVEI, ADTH
NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) --
Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are now investigating:
- Kintara Therapeutics, Inc. (Nasdaq: KTRA), relating to its proposed merger with TuHURA Biosciences, Inc. Click here for more information: https://monteverdelaw.com/case/kintara-therapeutics-inc/. It is free and there is no cost or obligation to you.
- ChampionX Corp. (Nasdaq: CHX), relating to its proposed sale to Schlumberger Ltd. Under the terms of the agreement, CHX shareholders are expected to receive 0.735 shares of Schlumberger per share they own. Click here for more information: https://monteverdelaw.com/case/championx-corp/. It is free and there is no cost or obligation to you.
- Nuvei Corp. (Nasdaq: NVEI), relating to its proposed sale to Advent International. Under the terms of the agreement, NVEI shareholders are expected to receive $34.00 in cash per share they own. Click here for more information: https://monteverdelaw.com/case/nuvei-corp/. It is free and there is no cost or obligation to you.
- AdTheorent Holding Co. (Nasdaq: ADTH), relating to its proposed sale to Cadent, LLC. Under the terms of the agreement, ADTH shareholders are expected to receive $3.21 in cash per share they own. Click here for more information: https://monteverdelaw.com/case/adtheorent-holding-co/. It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.
No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2024 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
![](https://ml.globenewswire.com/media/YTliYTZjM2UtMjk3NC00YzIxLTllZTAtNTg3NzgxNGRiOThkLTExOTU5MTM=/tiny/Monteverde-Associates-PC.png)
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Best- and Worst-Performing Stocks of Q2 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations